A5072278397- Nutrition, Genetics, and Disease
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Mobile Health and mHealth Applications
- Peptidase Inhibition and Analysis
- Chronic Lymphocytic Leukemia Research
- Hepatocellular Carcinoma Treatment and Prognosis
- Vascular Tumors and Angiosarcomas
- Innovative Human-Technology Interaction
- Pancreatic and Hepatic Oncology Research
- HER2/EGFR in Cancer Research
- Gastric Cancer Management and Outcomes
- Central Venous Catheters and Hemodialysis
- Lung Cancer Treatments and Mutations
- Intensive Care Unit Cognitive Disorders
- Sarcoma Diagnosis and Treatment
- Cardiac tumors and thrombi
- Obesity, Physical Activity, Diet
- Anesthesia and Sedative Agents
- Acute Kidney Injury Research
- Neuroendocrine Tumor Research Advances
- Anesthesia and Neurotoxicity Research
- Urinary Tract Infections Management
University of Wollongong
2023
Anhui Medical University
2022
Chinese People's Liberation Army
2020-2021
307th Hospital of Chinese People’s Liberation Army
2020
81th Hospital of PLA
2008
The Australian Dietary Guidelines (ADG) translate the best available evidence in nutrition into food choice recommendations. However, adherence to ADG is poor Australia. Given that following a healthy diet can be potentially cost-effective strategy for lowering risk of chronic diseases, there an urgent need develop novel technologies individuals improve their ADG.This study describes development process and design prototype mobile app personalized dietary advice based on adults Australia,...
Human epidermal growth factor receptor 2 (H ER2) is a member of the ErbB family and key proto-oncogene in solid tumors. This pilot study investigated safety efficacy pyrotinib HER2-positive non-breast advanced Twenty-five patients with tumors excluding breast cancer were enrolled to receive pyrotinib-based therapy. The primary end point was progression-free survival (PFS). median PFS overall (OS) 3.5 months (95% CI: 2.2-5.0 months) 9.6 4.4-9.9 months), respectively. Ten lung 9 gastric had...
Abstract: The emergence of epidermal growth factor receptor ( EGFR ) exon 20 p.C797S is one the major resistance mechanisms for osimertinib. However, there are no standard care non-small cell lung cancer (NSCLC) patients after acquiring C797S currently, which brings significant challenges to post-osimertinib clinical management. In present study, we described a 52-year-old female patient with -mutated stage IV adenocarcinoma, who achieved partial response (PR) treatment gefitinib and...
The main therapeutic strategy for metastatic Myxofibrosarcoma (MFS) is palliative chemotherapy. A number of studies have demonstrated that anti-angiogenic therapy and immunotherapy could improve the survival rate patients with metastases. However, effectiveness combination MFS undetermined. current study reports a case myxofibrosarcoma was treated Nivolumab (monoclonal antibody, PD-1 inhibitor) Bevacizumab anti-VEGF) after progression from single use Nivolumab. aim to assess efficacy safety...
Objective Peripherally inserted central catheters (PICCs), the most frequent venous catheter, are used to provide medical treatments, although long-term PICC-related adverse outcomes unknown in China. This study systematically investigated complications four Chinese hospitals. Methods Between January 2014 and 2020, we analyzed results of 3550 patients with PICC who were referred All underwent treatment Patient-reported signs symptoms a putative complication or functional studied. Long-term...
Small-cell lung cancer (SCLC) is sensitive to chemoradiotherapy but remains have a poor prognosis. In the immunotherapy era, chemotherapy combined with PD-L1 inhibitors has become new first-line treatment option for advanced SCLC. The CheckMate 032 study PD-1 blockade and CTLA-4 inhibitor found that this dual might be positive choice our case, patient SCLC received bevacizumab over third line more than 12 months survival time. overall time was 21.5 from start of third-line 39...
Introduction: Postoperative delirium (POD) is one of the prevalent and potentially fatal clinical conditions, leading to high disability mortality in older patients, as well increased duration hospital stay more hospitalization expenses. There were no effective drugs management POD, an absence evidence-based medicine concerning treatment POD. Materials Methods: The present study explored whether atorvastatin (Ato) can decrease occurrence rate research included patients over age 60 who...
<sec> <title>BACKGROUND</title> The Australian Dietary Guidelines (ADG) translate the best available evidence in nutrition into food choice recommendations. However, adherence to ADG is poor Australia. Given that following a healthy diet can be potentially cost-effective strategy for lowering risk of chronic diseases, there an urgent need develop novel technologies individuals improve their ADG. </sec> <title>OBJECTIVE</title> This study describes development process and design prototype...